Erich Tauber is the founder of Themis Bioscience. Themis Bioscience has raised $95M in total funding. Latest round: Series D. Based in Vienna, Austria.
Erich Tauber, MD, is the founder and CEO of Themis Bioscience, a biotechnology company that developed a proprietary measles-virus vector platform. He led the company through multiple clinical programs and secured over €90 million in funding before Themis was acquired by Merck Sharp & Dohme (MSD). Tauber continues to work within MSD as part of an independent entity focused on pandemic preparedness and vaccine development.
Full founder directory · Investor directory · Company funding database · Fundraising library